Call for Late Breaking Abstract Submission!

Key Dates

Call for Abstract	6 September 2021
Abstract Submission Deadline	17 January 2022
*Late Breaking Abstract Submission Deadline	18 February 2022
Author Notification	Abstract results will be announced on a rolling basis starting from January 2022
Registration Deadline for Accepted Presenters	1 March 2022

Abstract Themes

Submission Guidelines

To submit abstract, please prepare the following information:

• Presenting Author’s and Co-authors’ Details.
• Full First and Family Name(s).
• Affiliation Details: department, institution / hospital, city, state (if relevant), country, email address.
• Abstract Title: limited to 25 words in UPPER CASE.
• Abstract text: limited to 300 words, including acknowledgements. We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.
• Abstracts should clearly state:
  • Background and Aims
  • Methods
  • Results
  • Conclusions
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appear the first time.
• Use generic names of drugs. Express numbers as numerals.
• Abstract Themes: abstracts must be allocated to a specific category for the Scientific Program. You will need to select the category most suited to your abstract.
• Tables: A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract. When including a table, it is recommended to save the table as an image (JPG format).
• Graphs and Images: A maximum of 2 images can be included per abstract. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel.
• Graphs and images may be uploaded in JPG, PNG or GIF format only.

General Policy

• Submitters can submit up to 2 abstracts.
• Abstracts must be received by the stipulated submission deadline. Abstracts received after the deadline will not be considered.
• Abstracts must be original and must not be or have been published or presented at any other congress prior to The 11th Virtual Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2022 Virtual Congress).
• Abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
• Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
• Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline (20 December 2021, GMT+8). Therefore, the submitter will be required to create a user account.
• The submitted / draft abstracts cannot be edited after the submission deadline (20 December 2021, GMT+8). Please note that after final submission, the content of your abstract cannot be modified or corrected and that it will be published exactly as submitted.
• Before submitting the abstract, the Abstract Submitter will be required to confirm the followings:
  1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
  2. Submission of the abstract constitutes my consent to all Congress’ publications (e.g. Congress website, programs, other promotions, etc.)
  3. The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content”) provided to The 11th Virtual Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2022 Virtual Congress). The publication of the abstract does not infringe any third-party rights including, but not limited to, intellectual property rights.
  4. The Abstract submitted is original and have not been published or presented at any other congress prior to The 11th Virtual Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2022).
  5. The Organizers reserve the right to remove an abstract which does not comply with the above from any publication.
  6. The Abstract Submitter grants the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.
  7. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.
• Presenting author of abstracts must be registered participants.
• Each presenting author can only present up to 2 abstracts.
  Please note: Registration fees must be received by the Congress Secretariat by 1 March 2022, to ensure inclusion of the abstract in the Congress publications and in order to be scheduled for presentation.
• Accepted abstracts will be published in the official Congress publications, which will be provided in digital copy only.

Disclosure

Disclosure of financial relationships that the author(s) may have with the manufacturer/supplier of any commercial products or services related to the work, should be indicated in the appropriate box on the abstract form.

Abstract selection and Presentation

Participants interested in presenting an oral or poster presentation are invited to submit an abstract. All abstracts will undergo review by the ASPIRE 2022 Virtual Congress Scientific Committee. The Committee will determine whether abstracts will be accepted as oral or poster presentations with consideration to be given to the author’s preference. All abstracts will be reviewed by the Scientific Committee. Submitting authors will be notified via e-mail on rolling basis regarding the status of their abstract acceptance.